Colfax Corporation (CFX)
CFX Price and Sentiment
CFX Latest news
Colfax Corporation's (CFX) CEO Matt Trerotola on Q3 2021 Results - Earnings Call Transcript
Colfax's (CFX) Q3 earnings reflect the impacts of improved sales, margin expansion, supply-chain woes and logistics issues. For 2021, it lowers earnings projections on high taxes and pandemic woes.
Colfax (CFX) delivered earnings and revenue surprises of 0.00% and 1.57%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Colfax Corp (NYSE: CFX) reported third-quarter sales growth of 20% year-over-year to $965.89 million, +15% on an organic sales-per-day basis, beating the consensus of $958.430 million. Adjusted EPS improved to $0.54 from $0.41 in 3Q20, beating the consensus of $0.53.
Starboard supports Colfax's plan to split into two businesses, but there are other ways to improve profitability.
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WILMINGTON, DE, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the third quarter of 2021 on the morning of Thursday, November 4, 2021. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-888-771-4371 (U.S. callers) and +1-847-585-4405 (International callers) and referencing the conference ID number 50243903 and through webcast via Colfax's website www.colfaxcorp.com under the “Investors” section.
DALLAS--(BUSINESS WIRE)-- #djo--DJO® Expands Active, Adaptive Healing Offerings with Introduction of MedShape® DynaNail Hybrid™
Colfax (CFX) to gain from robust demand, product innovation, cost actions and synergies from buyouts. Inflation in raw material costs and supply-chain issues are likely to hurt.